awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34496122-ED29692A-7705-4ECC-ACA7-6D90385EC886
Q34496122-ED29692A-7705-4ECC-ACA7-6D90385EC886
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34496122-ED29692A-7705-4ECC-ACA7-6D90385EC886
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
P2860
Q34496122-ED29692A-7705-4ECC-ACA7-6D90385EC886
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34496122-ED29692A-7705-4ECC-ACA7-6D90385EC886
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dad3046e61c2c2418e55888f29d76169517d4768
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.